CML – Chronic Myeloid Leukemia, Chronic Myelogenous Leukemia
Understanding this condition
Chronic myelogenous leukemia (CML) is an uncommon type of cancer of the blood cells. It's considered chronic leukemia because it usually progresses more slowly than acute leukemia, sometimes over the course of years.
Any type of cancer can be frightening, of course. And unfortunately, CML is not a solid tumor that can be surgically removed. But the good news is that the prognosis for people with chronic myelogenous leukemia may be improving because of new medications to treat the condition. Although a bone marrow transplant may still be an option, many people with chronic myelogenous leukemia are able to manage their condition long term with the use of chemotherapy-like pills.
In fact, people can live with this kind of cancer for many years if it goes into remission. But of course, that also means that you must find healthy ways to cope emotionally with having a serious, chronic condition.
Source: MayoClinic.com
Back to Index of Diseases & Conditions
OUR PRODUCTS
Novartis is recognized worldwide for bringing to market innovative medicines with improved efficacy and fewer side-effects.
ACCESS TO MEDICINES
Novartis puts patients first. We want to create value for all patients, including those who cannot afford treatment. That is why we established Patient Assistance Now, a resource that allows you to access programs that may help you pay for your Novartis medicines.
PATIENT ASSISTANCE PROGRAMS
Through our Patient Assistance Programs, we are committed to providing access to our medications for those most in need.